Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 41, No. 1, 2008   

Free Abstract     Article (References)     Article (PDF 486 KB)     

Original Paper

Reduction of Capsular Thickness around Silicone Breast Implants by Zafirlukast in Rats
A. Spanoa, B. Palmierib, T. Palmizi Taidellia, M.B. Navaa

aPlastic Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, and
bDepartment of General Surgery and Surgical Specialties, University of Modena and Reggio Emilia, Modena and Reggio Emilia, Italy

Address of Corresponding Author

Eur Surg Res 2008;41:8-14 (DOI: 10.1159/000121501)


 goto top of page Key Words

  • Capsular thickness
  • Silicone breast implant
  • Zafirlukast
  • Leukotriene

 goto top of page Abstract

Capsular contracture is a very disappointing complication, with an overall incidence between 0.5 and 30% of breast implant operations and, if severe, requiring a further surgical procedure (capsulotomy or capsulectomy). Many frustrating attempts have been made to prevent the fibrotic reaction, mainly with steroids or antibiotics. More recently leukotriene antagonists clinically used in the asthma and lung diseases have been suggested to be potentially useful in counteracting the inflammatory pathway leading to a dense collagen membrane around the prosthesis and thus preventing contracture of the capsule. In this study we evaluated the effectiveness of zafirlukast with the following protocol. Disks of textured implant material were placed dorsally into each of the subcutaneous tissues of 40 rats that were subdivided in 2 groups: 20 rats treated with zafirlukast and 20 controls. At autopsy 77 days after, each implant with its surrounding collagenic tissue was excised, and the macroscopic measure of the membrane thickness was compared with the pathology reports, to definitely assess the foreign body reaction. The mean total thickness of the capsule around the implants was 161.97 µm in the zafirlukast-treated group compared with 345.98 µm in the control group (p < 0.001). Outstandingly, the collagen fibers and fibroblast layer were reduced in the zafirlukast-treated group compared to the controls. Our study confirms the effectiveness of this compound in preventing fibrosis and putatively also in reducing the extent of collagen reaction when a capsule has been formed.

Copyright © 2008 S. Karger AG, Basel


 goto top of page Author Contacts

Andrea Spano, MD
Plastic Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori
Via Venezian 1
IT-20133 Milan (Italy)
E-Mail andrea.spano@istitutotumori.mi.it


 goto top of page Article Information

Received: August 7, 2007
Accepted after revision: December 18, 2007
Published online: March 27, 2008
Number of Print Pages : 7
Number of Figures : 4, Number of Tables : 0, Number of References : 21

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 18367842)
Download Citation
Cited In



This journal is part of the second subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their research paper editing service.





copyright  © 2009 S. Karger AG, Basel